Correlation Between Oncorus and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Oncorus and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Oncorus and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Acrivon Therapeutics,.
Diversification Opportunities for Oncorus and Acrivon Therapeutics,
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Oncorus and Acrivon is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Oncorus i.e., Oncorus and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Oncorus and Acrivon Therapeutics,
If you would invest 4.35 in Oncorus on September 23, 2024 and sell it today you would earn a total of 0.00 from holding Oncorus or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.54% |
Values | Daily Returns |
Oncorus vs. Acrivon Therapeutics, Common
Performance |
Timeline |
Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acrivon Therapeutics, |
Oncorus and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncorus and Acrivon Therapeutics,
The main advantage of trading using opposite Oncorus and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
Acrivon Therapeutics, vs. Fate Therapeutics | Acrivon Therapeutics, vs. Sana Biotechnology | Acrivon Therapeutics, vs. Caribou Biosciences | Acrivon Therapeutics, vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |